ESR1 and breast cancer: Interestingly, beta-catenin knockdown also hindered the hypoxia-induced down-regulation of ESR1 (Figure 2D), revealing the capability of beta-catenin to play a pivotal role in the hypoxia-induced de-differentiation program that parallels the gain of stem cell features in breast cancer cells.